AVCN.TO
Avicanna Inc
Price:  
0.27 
CAD
Volume:  
364,582.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-
Upside

As of 2025-07-01, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -15.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 29.38 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -1.91 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.27 CAD
Stock Price
- CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-27 -15.42
2025-06-26 -14.84
2025-06-25 -14.55
2025-06-24 -15.13
2025-06-23 -14.84
2025-06-20 -15.42
2025-06-19 -14.26
2025-06-18 -13.97
2025-06-16 -14.26
2025-06-13 -13.68
2025-06-12 -14.55
2025-06-11 -14.26
2025-06-10 -13.68
2025-06-09 -14.84
2025-06-06 -16.00
2025-06-05 -15.13
2025-06-04 -14.55
2025-06-03 -14.84
2025-06-02 -14.84
2025-05-30 -15.42
2025-05-29 -15.13
2025-05-28 -15.13
2025-05-27 -15.42
2025-05-26 -16.00
2025-05-23 -15.13
2025-05-22 -16.00
2025-05-21 -16.00
2025-05-20 -16.00
2025-05-16 -16.29
2025-05-15 -16.29
2025-05-14 -13.68
2025-05-12 -14.26
2025-05-09 -14.26
2025-05-08 -14.26
2025-05-07 -14.26
2025-05-06 -14.55
2025-05-05 -14.26
2025-05-02 -13.39
2025-05-01 -13.39
2025-04-30 -13.97
2025-04-29 -13.97
2025-04-28 -13.11
2025-04-25 -13.97
2025-04-24 -15.13
2025-04-23 -14.26
2025-04-22 -14.84
2025-04-21 -13.97
2025-04-17 -13.11
2025-04-16 -13.68
2025-04-15 -14.84